Katrina Sweeney

522 total citations
10 papers, 422 citations indexed

About

Katrina Sweeney is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Katrina Sweeney has authored 10 papers receiving a total of 422 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Genetics and 3 papers in Oncology. Recurrent topics in Katrina Sweeney's work include RNA Interference and Gene Delivery (6 papers), Virus-based gene therapy research (5 papers) and CAR-T cell therapy research (3 papers). Katrina Sweeney is often cited by papers focused on RNA Interference and Gene Delivery (6 papers), Virus-based gene therapy research (5 papers) and CAR-T cell therapy research (3 papers). Katrina Sweeney collaborates with scholars based in United Kingdom, Australia and United States. Katrina Sweeney's co-authors include Gunnel Halldén, Nicholas R. Lemoine, Daniel Öberg, Colleen C. Nelson, Brett G. Hollier, Virginie Adam, Derek Davies, Enrique Miranda, Eva Yanover and Mona El‐Bahrawy and has published in prestigious journals such as Nucleic Acids Research, Cancer Research and Oncogene.

In The Last Decade

Katrina Sweeney

10 papers receiving 420 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Katrina Sweeney United Kingdom 8 310 166 135 111 68 10 422
Junjie Ye China 10 207 0.7× 95 0.6× 167 1.2× 117 1.1× 24 0.4× 17 385
Michael G. Lemoine United States 7 299 1.0× 349 2.1× 278 2.1× 68 0.6× 58 0.9× 7 532
Sebastian M. Dieter Germany 8 285 0.9× 62 0.4× 268 2.0× 143 1.3× 35 0.5× 14 490
Enric Xipell Spain 7 119 0.4× 74 0.4× 100 0.7× 33 0.3× 18 0.3× 8 218
Suzanne Dowson United Kingdom 7 170 0.5× 94 0.6× 177 1.3× 59 0.5× 19 0.3× 11 348
Daniel Garcia United States 6 276 0.9× 21 0.1× 160 1.2× 72 0.6× 37 0.5× 6 406
Yinghan Su China 9 204 0.7× 41 0.2× 71 0.5× 136 1.2× 14 0.2× 11 305
Mathijs Voorhoeve Singapore 7 164 0.5× 59 0.4× 77 0.6× 67 0.6× 17 0.3× 7 267
Sergio Lavilla-Alonso Finland 9 132 0.4× 140 0.8× 152 1.1× 17 0.2× 42 0.6× 11 268
Lisa van Voorthuijsen Netherlands 8 372 1.2× 81 0.5× 184 1.4× 81 0.7× 16 0.2× 8 556

Countries citing papers authored by Katrina Sweeney

Since Specialization
Citations

This map shows the geographic impact of Katrina Sweeney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katrina Sweeney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katrina Sweeney more than expected).

Fields of papers citing papers by Katrina Sweeney

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katrina Sweeney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katrina Sweeney. The network helps show where Katrina Sweeney may publish in the future.

Co-authorship network of co-authors of Katrina Sweeney

This figure shows the co-authorship network connecting the top 25 collaborators of Katrina Sweeney. A scholar is included among the top collaborators of Katrina Sweeney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katrina Sweeney. Katrina Sweeney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Evans, James, Meenakshi Malhotra, Katrina Sweeney, et al.. (2017). Folate-targeted amphiphilic cyclodextrin nanoparticles incorporating a fusogenic peptide deliver therapeutic siRNA and inhibit the invasive capacity of 3D prostate cancer tumours. International Journal of Pharmaceutics. 532(1). 511–518. 32 indexed citations
2.
Sweeney, Katrina, Nataly Stylianou, Atefeh Taherian Fard, et al.. (2017). Abstract 4909: Androgen targeted therapy induces ZEB1 expression and is associated with suppression of androgen signalling and therapy resistance. Cancer Research. 77(13_Supplement). 4909–4909. 1 indexed citations
3.
Halldén, Gunnel & Katrina Sweeney. (2016). Oncolytic adenovirus-mediated therapy for prostate cancer. PubMed. Volume 5. 45–57. 11 indexed citations
4.
Selth, Luke A., Rajdeep Das, Scott L. Townley, et al.. (2016). A ZEB1-miR-375-YAP1 pathway regulates epithelial plasticity in prostate cancer. Oncogene. 36(1). 24–34. 89 indexed citations
5.
Mura, Manuela, Roni M. Lahr, Normala Abd Latip, et al.. (2015). The RNA-binding protein LARP1 is a post-transcriptional regulator of survival and tumorigenesis in ovarian cancer. Nucleic Acids Research. 44(3). 1227–1246. 113 indexed citations
6.
Adam, Virginie, Maria Ekblad, Katrina Sweeney, et al.. (2012). Synergistic and Selective Cancer Cell Killing Mediated by the Oncolytic Adenoviral Mutant AdΔΔ and Dietary Phytochemicals in Prostate Cancer Models. Human Gene Therapy. 23(9). 1003–1015. 16 indexed citations
7.
Öberg, Daniel, Eva Yanover, Virginie Adam, et al.. (2010). Improved Potency and Selectivity of an Oncolytic E1ACR2 and E1B19K Deleted Adenoviral Mutant in Prostate and Pancreatic Cancers. Clinical Cancer Research. 16(2). 541–553. 54 indexed citations
8.
Sweeney, Katrina, Daniel Öberg, Derek Davies, et al.. (2009). Oncolytic Adenoviral Mutants with E1B19K Gene Deletions Enhance Gemcitabine-induced Apoptosis in Pancreatic Carcinoma Cells and Anti-Tumor Efficacy In vivo. Clinical Cancer Research. 15(5). 1730–1740. 60 indexed citations
9.
Wang, Yaohe, Jianghui Meng, Richard Hill, et al.. (2007). E1A-expressing adenoviral E3B mutants act synergistically with chemotherapeutics in immunocompetent tumor models. Cancer Gene Therapy. 15(1). 40–50. 44 indexed citations
10.
Sweeney, Katrina. (2005). Angiogenesis inhibitors: an upcoming therapy for cancer and wet age-related macular degeneration. Drug Discovery Today. 10(20). 1346–1348. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026